{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:27:54Z","timestamp":1790339274524,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Talent Training Plan of Medical Research Projects of PLA","award":["2021yxky004"],"award-info":[{"award-number":["2021yxky004"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,13]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Myositis ossificans (MO) is characterized by benign heterotopic ossificans in soft tissues like muscles, which can be classified into nonhereditary MO and fibrodysplasia ossificans progressiva (FOP). Nonhereditary MO is characterized by ossification of the soft tissues after acute or repetitive trauma, burns, or surgical intervention. FOP is a rare and crippling disease characterized by congenital malformation of the big toe and heterotopic ossification in muscle. The majority of FOP\u2019s musculoskeletal traits are associated with dysregulated chondrogenesis. The diagnosis is mainly based on clinical manifestation, imaging examination, and genetic analysis. There is still no effective treatment to cure or slow its progression. The best approach remains early diagnosis, conservative drug treatment, and injury prevention to avoid local ossification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 34-year-old male presented at our hospital because of trismus caused by ossification of the masseter muscle. In addition, he had serious stiffness and multiple bony masses throughout the body, which led to limited movement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Based on the clinical manifestation of movement restriction, characteristic radiographic images of ossification of soft tissues, the genetic test showing a heterozygous molecule (c.974G\u2005&gt;\u2005C, p.G325A) of the activin A receptor type I, the patient was diagnosed as FOP complicated with localized MO in masseter after trauma and infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient underwent the surgical resection of ossification in the masseter muscle, he was instructed to insist on mouth-opening exercises and take glucocorticoids and nonsteroidal anti-inflammatory medications after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The symptoms of trismus are relieved, and eating can be basically achieved after surgery, while the symptoms of trismus recurred 2 years later.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Although FOP has unique clinical manifestations, its diagnosis may be difficult because of its rarity. Gene analysis is the main standard for diagnosis, while patients with different genotypic variations may show different clinical symptoms. Therapeutic interventions are still supportive and preventive, and surgery is not recommended except under certain circumstances.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000039648","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T13:13:59Z","timestamp":1726578839000},"page":"e39648","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Fibrodysplasia ossificans progressiva complicated with post traumatic and infectious myositis ossificans in masseter: A case report"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2454-9586","authenticated-orcid":false,"given":"Yian","family":"Guan","sequence":"first","affiliation":[{"name":"Department of Orthodontics, School of Stomatology, Lanzhou University, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8863-2669","authenticated-orcid":false,"given":"Dongyang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, the 940th Hospital of Joint Logistics Support Force of PLA, Lanzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260203","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1530\/EOR-23-0207","article-title":"Research trends and hotspots of myositis ossificans: a bibliometric analysis from 1993 to 2022.","volume":"9","author":"Lai","year":"2024","journal-title":"EFORT Open Rev"},{"key":"R2-20260203","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13005-018-0180-6","article-title":"Myositis ossificans traumatica of the masticatory muscles: etiology, diagnosis and treatment.","volume":"14","author":"Hanisch","year":"2018","journal-title":"Head Face Med"},{"key":"R3-20260203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ped.14065","article-title":"Fibrodysplasia ossificans progressiva: review and research activities in Japan.","volume":"62","author":"Haga","year":"2020","journal-title":"Pediatr Int"},{"key":"R4-20260203","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.","volume":"38","author":"Shore","year":"2006","journal-title":"Nat Genet"},{"key":"R5-20260203","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s10067-022-06144-9","article-title":"Fibrodysplasia (myositis) ossificans progressiva (FOP).","volume":"41","author":"Ramirez-Gonzalez","year":"2022","journal-title":"Clin Rheumatol"},{"key":"R6-20260203","first-page":"113","article-title":"Monitoring and management of fibrodysplasia ossificans progressiva: current perspectives.","volume":"14","author":"Smilde","year":"2022","journal-title":"Orthop Res Rev"},{"key":"R7-20260203","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.joms.2017.03.005","article-title":"Restricted mandibular movement attributed to ossification of mandibular depressors and medial pterygoid muscles in patients with fibrodysplasia ossificans progressiva: a report of 3 cases.","volume":"75","author":"Okuno","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"key":"R8-20260203","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ejhg.2008.178","article-title":"Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements.","volume":"17","author":"Bocciardi","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"R9-20260203","doi-asserted-by":"crossref","first-page":"115116","DOI":"10.1016\/j.bone.2019.115116","article-title":"Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva.","volume":"130","author":"Towler","year":"2020","journal-title":"Bone"},{"key":"R10-20260203","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.injury.2020.12.019","article-title":"Soft tissue injury in the limbs increased regional bone turnover.","volume":"52","author":"Hayakawa","year":"2021","journal-title":"Injury"},{"key":"R11-20260203","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s13256-019-2297-z","article-title":"Fibrodysplasia ossificans progressiva (stone man syndrome): a case report.","volume":"13","author":"Shah","year":"2019","journal-title":"J Med Case Rep"},{"key":"R12-20260203","doi-asserted-by":"crossref","first-page":"e24620","DOI":"10.1097\/MD.0000000000024620","article-title":"Fibrodysplasia ossificans progressiva in a young adult with genetic mutation: case report.","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"R13-20260203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/biomedicines9020213","article-title":"Challenges and opportunities for drug repositioning in fibrodysplasia ossificans progressiva.","volume":"9","author":"Ventura","year":"2021","journal-title":"Biomedicines"},{"key":"R14-20260203","doi-asserted-by":"crossref","first-page":"115472","DOI":"10.1016\/j.bone.2020.115472","article-title":"Bone morphogenetic protein receptors: structure, function and targeting by selective small molecule kinase inhibitors.","volume":"138","author":"Sanchez-Duffhues","year":"2020","journal-title":"Bone"},{"key":"R15-20260203","doi-asserted-by":"crossref","first-page":"e8165","DOI":"10.1002\/ccr3.8165","article-title":"Fibrodysplasia ossificans progressiva.","volume":"11","author":"Smit","year":"2023","journal-title":"Clin Case Rep"},{"key":"R16-20260203","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s12015-020-10103-9","article-title":"ActivinA induced SMAD1\/5 signaling in an iPSC Derived EC model of fibrodysplasia ossificans progressiva (FOP) can be rescued by the drug candidate saracatinib.","volume":"17","author":"Hildebrandt","year":"2021","journal-title":"Stem Cell Rev Rep"},{"key":"R17-20260203","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12874-023-02080-7","article-title":"Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva.","volume":"23","author":"Pignolo","year":"2023","journal-title":"BMC Med Res Methodol"},{"key":"R18-20260203","first-page":"keae255","article-title":"Long term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva.","author":"Haviv","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R19-20260203","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12969-023-00856-1","article-title":"Successful experience of tofacitinib treatment in patients with fibrodysplasia ossificans progressiva.","volume":"21","author":"Nikishina","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"key":"R20-20260203","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1038\/s41591-023-02561-8","article-title":"Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial.","volume":"29","author":"Di Rocco","year":"2023","journal-title":"Nat Med"},{"key":"R21-20260203","doi-asserted-by":"crossref","first-page":"e95042","DOI":"10.1172\/jci.insight.95042","article-title":"Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva.","volume":"6","author":"Williams","year":"2021","journal-title":"JCI Insight"},{"key":"R22-20260203","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bone.2017.07.019","article-title":"Early clinical observations on the use of imatinib mesylate in FOP: a report of seven cases.","volume":"109","author":"Kaplan","year":"2018","journal-title":"Bone"},{"key":"R23-20260203","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jbspin.2005.10.017","article-title":"Myositis ossificans progressiva mimicking ankylosing spondylitis (a case report).","volume":"73","author":"Elloumi","year":"2006","journal-title":"Joint Bone Spine"},{"key":"R24-20260203","first-page":"437","article-title":"Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.","volume":"10","author":"Pignolo","year":"2013","journal-title":"Pediatr Endocrinol Rev"},{"key":"R25-20260203","doi-asserted-by":"crossref","first-page":"e19933","DOI":"10.1097\/MD.0000000000019933","article-title":"Fibrodysplasia ossificans progressiva-a rare disease with distinctive features yet still a diagnostic challenge: a case report.","volume":"99","author":"Shi","year":"2020","journal-title":"Medicine (Baltim)"},{"key":"R26-20260203","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/biom14030349","article-title":"Intersections of fibrodysplasia ossificans progressiva and traumatic heterotopic ossification.","volume":"14","author":"Juan","year":"2024","journal-title":"Biomolecules"},{"key":"R27-20260203","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1089\/hum.2022.023","article-title":"Gene therapy for fibrodysplasia ossificans progressiva: feasibility and obstacles.","volume":"33","author":"Eekhoff","year":"2022","journal-title":"Hum Gene Ther"},{"key":"R28-20260203","doi-asserted-by":"crossref","first-page":"dmm046441","DOI":"10.1242\/dmm.046441","article-title":"Fibrodysplasia ossificans progressiva: current concepts from bench to bedside.","volume":"13","author":"Kaliya-Perumal","year":"2020","journal-title":"Dis Model Mech"},{"key":"R29-20260203","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/biom14030357","article-title":"Immunologic aspects in fibrodysplasia ossificans progressiva.","volume":"14","author":"Diolintzi","year":"2024","journal-title":"Biomolecules"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:00:37Z","timestamp":1770138037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":29,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039648","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]}}}